Bayesian cost‐effectiveness analysis from clinical trial data
暂无分享,去创建一个
A O'Hagan | J W Stevens | J Montmartin | A. O'Hagan | John W. Stevens | J. Stevens | Jacques Montmartin | A. O’Hagan
[1] M Johannesson,et al. A Note on Confidence Intervals in Cost-Effectiveness Analysis , 1998, International Journal of Technology Assessment in Health Care.
[2] A H Briggs,et al. A Bayesian approach to stochastic cost-effectiveness analysis. , 1999, Health economics.
[3] A A Stinnett,et al. Net Health Benefits , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.
[4] David B. Dunson,et al. Bayesian Data Analysis , 2010 .
[5] A R Willan,et al. Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem. , 1996, Health economics.
[6] A Briggs,et al. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. , 1998, Health economics.
[7] A O'Hagan,et al. A framework for cost-effectiveness analysis from clinical trial data. , 2001, Health economics.
[8] David R. Jones,et al. An introduction to bayesian methods in health technology assessment , 1999, BMJ.
[9] R. Pauwels,et al. A 1-year comparison of turbuhaler vs pressurized metered-dose inhaler in asthmatic patients. , 1996, Chest.
[10] M Meisner,et al. Statistical inference for cost-effectiveness ratios. , 1997, Health economics.
[11] P. Wakker,et al. Confidence intervals for cost/effectiveness ratios. , 1995, Health economics.
[12] W C Black,et al. The CE Plane , 1990, Medical decision making : an international journal of the Society for Medical Decision Making.
[13] B. Liljas,et al. Cost-effectiveness analysis of a dry powder inhaler (Turbuhaler) versus a pressurised metered dose inhaler in patients with asthma. , 1997, PharmacoEconomics.
[14] M J Al,et al. Costs, effects and C/E-ratios alongside a clinical trial. , 1994, Health economics.
[15] A J Moskowitz,et al. Bayesian estimation of cost-effectiveness ratios from clinical trials. , 1999, Health economics.